Breaking News, Financial News

Financial Report: AMRI

Cedarburg business boosts large scale manufacturing revenue

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AMRI 2Q Revenues: $68.2 million (+15%) 2Q Earnings: $3.7 million (loss of $2.5 million in 2Q13) YTD Revenues: $127.5 million (+7%) YTD Earnings: $7.2 million (+90%) Comments: Contract revenue was $61.5 million, up 21% driven by increased capacity utilization and the addition of Cedarburg Pharmaceuticals. Discovery Services and Development/Small Scale Manufacturing (DDS) contract revenue in the quarter was flat at $19.5 million. Large Scale Manufacturing (LSM) contract revenue was $42.0 mill...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters